知镜 Cognispect · 医学文献与研究工作台

A WeChat-delivered Information-Motivation-Behavioral skills intervention to improve HPV vaccine acceptability among Chinese gay, bisexual, and other men who have sex with men

Liu Q, Lim SH, Wong LP.
Hum Vaccin Immunother · 2026-02-20 · PMID 41718239

文献摘要

Culturally appropriate strategies are urgently needed to promote human papillomavirus (HPV) vaccination among Chinese gay, bisexual, and other men who have sex with men. WeChat-based interventions guided by the Information - Motivation - Behavioral Skills (IMB) model offer a theory-driven approach by targeting knowledge, motivation, social norms, and self-efficacy. To evaluate a WeChat-delivered IMB-based intervention designed to improve HPV vaccine acceptability in this population. HPV vaccine acceptability and IMB constructs were assessed at baseline (T 0 ), immediately post-intervention (T 1 ), and 1 month post-intervention (T 2 ). Intervention effects were estimated using generalized estimating equations. Mediation was examined using Hayes' PROCESS macro (Model 4) based on change scores with bootstrapped confidence intervals (CIs). The intervention group reported significantly higher HPV vaccine acceptability at T 1 (β = 0.42, 95% CI [0.17, 0.68]; p  < .001), although effects attenuated at T 2 (β = 0.28, 95% CI [0.00, 0.56]; p  = .05). Within the intervention group, mean acceptability increased from 3.31 at T 0 to 3.86 at T 1 , representing a 16.6% increase. Significant improvements were also observed at T 1 in HPV knowledge, perceived severity, perceived effectiveness, anticipated regret, subjective norms, and self-efficacy, with partial declines observed at T 2 . Mediation analyses identified knowledge (β = 0.357, 95% CI [0.228, 0.487]), subjective norms (β = 0.356, 95% CI [0.288, 0.425]), and self-efficacy (β = 0.324, 95% CI [0.244, 0.405]) as key mediators of intervention effects. WeChat-delivered IMB intervention improved short-term HPV vaccine acceptability. Sustaining these effects will require additional strategies to ensure long-term sustainability. Clinical Trial Registration: ChiCTR2400089627.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。